Cash on Hand for IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's latest reported cash and short-term investments is $180.07M USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingCash on HandSwitch metric
Latest period
$180.07M
YoY change
-37.5%
5Y CAGR
-14.1%
Peak year (2017)
$471.93M
Latest annual
$180.07M
Cash on Hand history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Cash on Hand history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $180.07M | -37.5% | ||
| 2024 | $288.27M | -36.5% | ||
| 2023 | $453.93M | +303.3% | ||
| 2022 | $112.55M | -22.1% | ||
| 2021 | $144.45M | -62.4% | ||
| 2020 | $383.93M | +325.0% | ||
| 2019 | $90.33M | -27.0% | ||
| 2018 | $123.79M | -73.8% | ||
| 2017 | $471.93M | +20.4% | ||
| 2016 | $391.85M | +14.4% | ||
| 2015 | $342.58M | +6.2% | ||
| 2014 | $322.54M | +15.6% | ||
| 2013 | $279.06M | +24.6% | ||
| 2012 | $223.99M | +21.8% | ||
| 2011 | $183.90M | +17.2% | ||
| 2010 | $156.91M | +47.0% | ||
| 2009 | $106.73M | +35.3% | ||
| 2008 | $78.87M | +30.7% | ||
| 2007 | $60.36M | -37.6% | ||
| 2006 | $96.67M | -27.2% | ||
| 2005 | $132.73M | -3.3% | ||
| 2004 | $137.27M | -37.8% | ||
| 2003 | $220.71M | +49.9% | ||
| 2002 | $147.19M | +85.0% | ||
| 2001 | $79.56M | +5.8% | ||
| 2000 | $75.20M | +28.3% | ||
| 1999 | $58.60M | -46.3% | ||
| 1998 | $109.10M | +2.0% | ||
| 1997 | $107.00M | -16.2% | ||
| 1996 | $127.70M | -14.5% | ||
| 1995 | $149.30M | +492.5% | ||
| 1994 | $25.20M | +33.3% | ||
| 1993 | $18.90M | +9.9% | ||
| 1992 | $17.20M | +84.9% | ||
| 1991 | $9.30M | — |
Cash on Hand values are taken from IDEXX Laboratories's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual cash and short-term investments for IDEXX Laboratories (IDXX) came in at $180.07M – plunged 37.5% year-over-year.
Looking at the 2020–2025 (5 years) stretch, IDEXX Laboratories cash and short-term investments compounded at -14.1% per year, with a net decline across the window.
IDEXX Laboratories cash and short-term investments plunged from $471.93M in 2017 to $180.07M in 2025, a 61.8% drawdown.
$471.93M stands as the all-time-high annual cash and short-term investments, posted in 2017, against a low of $9.30M during 1991.
Among 8 Healthcare peers, IDEXX Laboratories (IDXX) ranks 9th; the peer median for cash and short-term investments is $11.85B.
IDEXX Laboratories Cash on Hand by Year
IDEXX Laboratories Cash on Hand 2025: $180.07M
IDEXX Laboratories cash and short-term investments in 2025 was $180.07M, plunged 37.5% below 2024.
IDEXX Laboratories Cash on Hand 2024: $288.27M
IDEXX Laboratories cash and short-term investments in 2024 was $288.27M, plunged 36.5% below 2023.
IDEXX Laboratories Cash on Hand 2023: $453.93M
IDEXX Laboratories cash and short-term investments in 2023 was $453.93M, surged 303.3% from 2022.
IDEXX Laboratories Cash on Hand 2022: $112.55M
IDEXX Laboratories cash and short-term investments in 2022 was $112.55M, declined 22.1% below 2021.
IDEXX Laboratories Cash on Hand 2021: $144.45M
IDEXX Laboratories cash and short-term investments in 2021 was $144.45M.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers — Cash on Hand
Companies in the same sector as IDEXX Laboratories, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is IDEXX Laboratories's cash and short-term investments?
- Latest reported cash and short-term investments for IDEXX Laboratories (IDXX) is $180.07M (period ending December 31, 2025).
How has IDEXX Laboratories cash and short-term investments changed year-over-year?
- IDEXX Laboratories (IDXX) cash and short-term investments changed -37.5% year-over-year on the latest annual filing.
What is the long-term growth rate of IDEXX Laboratories cash and short-term investments?
- IDEXX Laboratories (IDXX) cash and short-term investments compound annual growth rate is -14.1% over the most recent 5 years available.
When did IDEXX Laboratories cash and short-term investments hit its highest annual value?
- IDEXX Laboratories cash and short-term investments reached its highest annual value of $471.93M in 2017.
What was IDEXX Laboratories cash and short-term investments in 2024?
- IDEXX Laboratories (IDXX) cash and short-term investments in 2024 was $288.27M.
What was IDEXX Laboratories cash and short-term investments in 2025?
- IDEXX Laboratories (IDXX) cash and short-term investments in 2025 was $180.07M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
IDXX Overview
Company profile, financial tools, and key metrics
IDXX Revenue Counter
Earns $136.47 every second. See per minute, hour, and day.
IDXX Earnings Counter
Earns $33.60 per second net profit. See per minute, hour, and day.
IDXX Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
IDXX What If Invested
What if you had invested $1,000? See historical returns from any date.
IDXX How It Makes Money
Discover visual breakdown of $4.30B in revenue — where it comes from and where it goes.
IDXX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
IDXX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
IDXX Daily Price Character
Explosive · 50.9% historical win rate (green days). Streaks & record days.
IDXX Buybacks
2.25% TTM buyback yield. Shareholder yield & SBC comparison.
IDXX Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.